Nuclein, LLC

Amendment
CIK: 0001787352·Biotechnology·TEXAS·Filed: Aug 14, 2026
Total Offering

$16,114,842

Amount Sold

$9,253,488

Investors

15

First Sale

Jun 4, 2026

Offering Details

Type
Debt
Exemptions
Rule 506(b)
Entity Type
Limited Liability Company
Non-Accredited Investors
No

Related Persons

NameRole
Alan Blake
Richard Crockett
William Cunningham
Douglas Bryant
Sanjay Chandra
H. David Shockley
Walter Narajowski
Jeffrey Stukuls

Company

Nuclein, LLC

8305 CROSS PARK DR

AUSTIN, TX, 78754

512-879-3301

SEC Filing

0001787352-26-000004

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free